Outlook Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2020 and Provides Corporate Update


You May Also Like

BeiGene Appoints Ross Pettit as Senior Vice President, Global Development Operations

WALTHAM, Mass., Oct. 03, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

IMV to Present at 2019 BIO CEO & Investor Conference

DARTMOUTH, Nova Scotia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: ...